Search

Your search keyword '"Di Maio, Massimo"' showing total 1,184 results

Search Constraints

Start Over You searched for: Author "Di Maio, Massimo" Remove constraint Author: "Di Maio, Massimo"
1,184 results on '"Di Maio, Massimo"'

Search Results

3. Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)

6. Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects

7. Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancer

8. Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives

11. Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies

12. Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study

14. Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group

20. Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis

21. Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations

24. Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study

25. Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study

26. Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer

29. Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial

30. Maximal androgen blockade therapy (MAB) for prostate cancer (PC) and risk of bone fractures: A systematic literature review and meta-analysis.

31. Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index

32. Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial

34. Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

35. High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status

37. A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma

38. Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study

39. Clinical Trials and Methodology of Cancer Research

43. Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer

45. Second medical opinion in oncological setting

46. Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis

47. A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system

50. Challenges and controversies in resectable non-small cell lung cancer:a clinician's perspective

Catalog

Books, media, physical & digital resources